MedPath

Western History Collection

Western History Collection logo
🇺🇸United States
Ownership
Private
Established
1890-01-01
Employees
10K
Market Cap
-
Website
http://www.ou.edu

Clinical Trials

402

Active:20
Completed:203

Trial Phases

6 Phases

Early Phase 1:16
Phase 1:31
Phase 2:40
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (335 trials with phase data)• Click on a phase to view related trials

Not Applicable
219 (65.4%)
Phase 2
40 (11.9%)
Phase 1
31 (9.3%)
Phase 4
19 (5.7%)
Early Phase 1
16 (4.8%)
Phase 3
10 (3.0%)

The Hysterosalpingogram (HSG) Experience And Tubal Spasm (HEAT) Study

Not Applicable
Not yet recruiting
Conditions
Infertility
Interventions
Drug: Warmed HSG
First Posted Date
2025-11-10
Last Posted Date
2025-11-10
Lead Sponsor
University of Oklahoma
Target Recruit Count
240
Registration Number
NCT07226310
Locations
🇺🇸

University of Oklahoma Health Center, Oklahoma City, Oklahoma, United States

The Effects of Ketone Supplements With Carbohydrates on Cycling Performance Above Lactate Threshold

Not Applicable
Not yet recruiting
Conditions
Exogenous Ketosis
First Posted Date
2025-11-04
Last Posted Date
2025-11-04
Lead Sponsor
University of Oklahoma
Target Recruit Count
15
Registration Number
NCT07224282
Locations
🇺🇸

University of Oklahoma, Norman, Oklahoma, United States

Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma

Not Applicable
Not yet recruiting
Conditions
Clear Cell Renal Cell Carcinoma
Interventions
Drug: Cemiplimab 350 MG Intravenous Solution
Drug: Fianlimab 1600 MG Intravenous Solution
First Posted Date
2025-11-03
Last Posted Date
2025-11-03
Lead Sponsor
University of Oklahoma
Target Recruit Count
72
Registration Number
NCT07223541
Locations
🇺🇸

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

Dietary Fiber and Time Restricted Eating

Not Applicable
Recruiting
Conditions
Diet Habits
Cancer Prevention
First Posted Date
2025-10-22
Last Posted Date
2025-10-24
Lead Sponsor
University of Oklahoma
Target Recruit Count
90
Registration Number
NCT07219706
Locations
🇺🇸

University of Oklahoma Health Sciences, Columbus, Ohio, United States

Program in Oncology for Tribal Health Systems.

Not yet recruiting
Conditions
Patient Outcomes
First Posted Date
2025-10-16
Last Posted Date
2025-10-16
Lead Sponsor
University of Oklahoma
Target Recruit Count
187
Registration Number
NCT07217574
Locations
🇺🇸

OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 81
  • Next

News

University of Oklahoma Researchers Unlock Amylin Receptor Mechanisms for Next-Generation Obesity Drugs

University of Oklahoma researchers published breakthrough findings in Science Signaling revealing new understanding of how amylin receptors function, providing crucial insights for obesity drug development.

Smart-T Smoking Cessation App Shows Nearly Double Quit Rates in Low-Income Adults

University of Oklahoma researchers developed Smart-T, a real-time adaptive smartphone app that nearly doubled smoking cessation rates compared to a static app in a clinical trial of 454 low-income smokers.

Novel Hafnium-Based Treatment Trial Launches for Cisplatin-Ineligible Head and Neck Cancer Patients

International researchers launch NANORAY-312 trial investigating hafnium metal therapy combined with radiation as a novel treatment approach for head and neck cancer patients unsuitable for cisplatin treatment.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.